University of Ioannina
Ο ρόλος της κυτταρομετρίας ροής στη μελέτη του ορθοκολικού καρκίνου και στην ανάδειξη προγνωστικών παραγόντων
Abstract
dc:descriptionBackground: Colorectal cancer (CRC) is still accompanied by significant mortality, which poses the necessity of novel markers to predict treatment success and patient survival. Flow Cytometry is an analytical technique for the precise quantification of cellular phenotype. Intraoperative Flow Cytometry (iFC) utilizes flow cytometry during surgery for tissue DNA content/ploidy and cell cycle distribution analysis to identify cancer cells and to evaluate the tumor margins. Various types of cancers, including intracranial, head and neck, breast and liver malignancies have been evaluated with iFC. In the current study, we present an intraoperative Flow Cytometry protocol for colorectal cancer cell detection and potential resection margin evaluation. In addition, we evaluated the prognostic and survival impact of flow cytometry (FC) in CRC patients. Materials and methods: This prospective study includes 106 colorectal cancer patients in which samples from cancer and normal colon epithelium were collected intraoperatively and comparatively assessed with iFC. Patients’ demographics, tumor data and cytometry parameters were assessed. DNA and tumor index were calculated. In a subgroup of 46 patients, the CD26 expression on tumor cells was estimated. These parameters were compared with patients’ tumor characteristics as stage, histology data, responsiveness to treatment, metastasis/recurrence, and, finally, patients’ survival to identify possible new biomarkers. Results: We have demonstrated that a cut-off value of 10.5% for tumor-index (fraction of cells in S and G2/M cell cycle phases) predicts with ~91% accuracy (82.2% sensitivity and 99.9% specificity) the presence of cancer cells. Evaluation of tumor margins by iFC in the subpopulation of rectal cancer patients with or without neoadjuvant therapy, revealed an accuracy of 79% and 88%, respectively. The overall survival and the disease-specific survival in our study group were 76% and 72%, respectively, during the 7-year follow-up period. Diploid tumors had better median survival than the aneuploid ones. The DNA index had significant correlation to the tumor index and response to neoadjuvant treatment. Similarly, the tumor index was also significantly related to the response to neoadjuvant treatment. Patients with a higher tumor index had worst survival rates. Surprisingly, CD26 levels were not associated with any of the parameters examined and were negatively related to tumor stage and differentiation. Conclusion: FC is a rapid and reliable method of cell analysis. In CRC, it has been used for prognostic and diagnostic purposes. Our data supports that regarding colorectal cancer, iFC is a useful adjunct method for tumor cell identification and probably margin evaluation, which could be utilized in rectal cancer treatment in the era of organ sparing procedures. In this study, we have also shown that DNA and tumor index could become predictive biomarkers of tumor response to neoadjuvant treatment and survival of resectable CRC patients.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georvasili, Vaia
- Γεωρβασίλη, Βάια
Subjects
dc:subject × 18- Κυτταρομετρία ροής
- Ορθοκολικός καρκίνος
- Διεγχειρητική κυτταρομετρία ροής (iFC)
- Flow cytometry
- Colorectal cancer
- Intraoperative flow cytometry (iFC)
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Χειρουργική
- Ογκολογία
- Άλλες Ιατρικές Επιστήμες
- Ιατρική έρευνα και Πειραματική ιατρική
- Clinical Medicine
- Medical and Health Sciences
- Surgery
- Oncology
- Other Medical Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59025